Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 248K - 248K
Notice Type:
Contract award notice
Published Date:
05 August 2016
Closing Date:
Location(s):
ES ESPAÑA (ES Spain/ESPAÑA)
Description:

Adquisición de la especialidad farmacéutica Omalizumab (Xolair).

Awarded to:
Novartis Farmacéutica, S.A., Barcelona (ES)
Download full details as .pdf
The Buyer:
Hospital Infantil Universitario Niño Jesús
CPV Code(s):
33600000 - Pharmaceutical products